Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A prospective, multinational, multicenter trial to compare the effects of amlodipine/benazepril to benazepril and hydrochlorothiazide combined on the reduction of cardiovascular morbidity and mortality in patients with high risk hypertension

Trial Profile

A prospective, multinational, multicenter trial to compare the effects of amlodipine/benazepril to benazepril and hydrochlorothiazide combined on the reduction of cardiovascular morbidity and mortality in patients with high risk hypertension

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 26 Oct 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Amlodipine/benazepril (Primary) ; Benazepril/hydrochlorothiazide
  • Indications Cardiovascular disorders; Hypertension
  • Focus Therapeutic Use
  • Acronyms ACCOMPLISH
  • Sponsors Novartis
  • Most Recent Events

    • 20 Nov 2020 Results of post hoc analysis (n=5221) comparing the primary composite outcome between the 2 combination-treatment limbs in patients achieving a desired systolic blood pressure and those with apparent resistant hypertension, published in the American Journal of Hypertension
    • 30 Aug 2010 A late-breaking analysis reviewing 21 trials, including ACCOMPLISH, was presented at the European Society of Cardiology (ESC) Congress, according to a European Society of Cardiology media release.
    • 01 Jul 2010 Results of a sub-study on effects on 24-hour ambulatory blood pressure were presented in the New England Journal of Medicine, available from http://dx.doi.org/10.1056/nejmc1001410.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top